2022 Q4 Form 10-Q Financial Statement
#000149315222032176 Filed on November 14, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
Revenue | $752.0K | $97.00K | $499.0K |
YoY Change | -2.97% | -80.56% | 232.67% |
Cost Of Revenue | $585.0K | $17.00K | $271.0K |
YoY Change | 12.93% | -93.73% | 442.0% |
Gross Profit | $167.0K | $80.00K | $228.0K |
YoY Change | -35.02% | -64.91% | 128.0% |
Gross Profit Margin | 22.21% | 82.47% | 45.69% |
Selling, General & Admin | $4.896M | $955.0K | $1.046M |
YoY Change | 84.62% | -8.7% | 24.52% |
% of Gross Profit | 2931.74% | 1193.75% | 458.77% |
Research & Development | $283.0K | $49.00K | $50.00K |
YoY Change | 146.09% | -2.0% | -28.57% |
% of Gross Profit | 169.46% | 61.25% | 21.93% |
Depreciation & Amortization | $0.00 | $1.000K | $0.00 |
YoY Change | -100.0% | ||
% of Gross Profit | 0.0% | 1.25% | 0.0% |
Operating Expenses | $5.179M | $1.004M | $1.096M |
YoY Change | 87.17% | -8.39% | 21.78% |
Operating Profit | -$5.012M | -$924.0K | -$868.0K |
YoY Change | 99.68% | 6.45% | 8.5% |
Interest Expense | -$401.0K | -$16.00K | |
YoY Change | 2010.53% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Pretax Income | -$5.413M | -$940.0K | -$6.605M |
YoY Change | 114.04% | -85.77% | 602.66% |
Income Tax | $35.00K | $15.00K | $70.00K |
% Of Pretax Income | |||
Net Earnings | -$5.448M | -$955.0K | -$6.675M |
YoY Change | 120.21% | -85.69% | 625.54% |
Net Earnings / Revenue | -724.47% | -984.54% | -1337.68% |
Basic Earnings Per Share | -$0.03 | -$0.26 | |
Diluted Earnings Per Share | -$3.84 | -$34.11K | -$255.8K |
COMMON SHARES | |||
Basic Shares Outstanding | 28.00M shares | 28.00M shares | 26.10M shares |
Diluted Shares Outstanding | 1.400M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.713M | $1.972M | $8.599M |
YoY Change | -64.93% | -77.07% | 170.41% |
Cash & Equivalents | $2.713M | $1.972M | $8.599M |
Short-Term Investments | |||
Other Short-Term Assets | $100.0K | $1.238M | $597.0K |
YoY Change | -56.52% | 107.37% | 17.06% |
Inventory | $2.175M | $1.553M | $201.0K |
Prepaid Expenses | $612.0K | ||
Receivables | $9.000K | $226.0K | $28.00K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $5.609M | $4.989M | $9.425M |
YoY Change | -32.76% | -47.07% | 141.67% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $7.000K | $8.000K | $26.00K |
YoY Change | 40.0% | -69.23% | |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $3.000K | $7.000K | $215.0K |
YoY Change | -84.21% | -96.74% | 7.5% |
Total Long-Term Assets | $270.0K | $221.0K | $241.0K |
YoY Change | -3.57% | -8.3% | 20.5% |
TOTAL ASSETS | |||
Total Short-Term Assets | $5.609M | $4.989M | $9.425M |
Total Long-Term Assets | $270.0K | $221.0K | $241.0K |
Total Assets | $5.879M | $5.210M | $9.666M |
YoY Change | -31.81% | -46.1% | 135.76% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $66.00K | $41.00K | $62.00K |
YoY Change | -24.14% | -33.87% | -31.11% |
Accrued Expenses | $81.00K | $28.00K | $10.00K |
YoY Change | 65.31% | 180.0% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.316M | $1.715M | $266.0K |
YoY Change | 21.7% | 544.74% | -26.11% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $330.0K | $341.0K | $689.0K |
YoY Change | -18.72% | -50.51% | 56.59% |
Total Long-Term Liabilities | $330.0K | $341.0K | $689.0K |
YoY Change | -18.72% | -50.51% | 46.6% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.316M | $1.715M | $266.0K |
Total Long-Term Liabilities | $330.0K | $341.0K | $689.0K |
Total Liabilities | $2.646M | $2.056M | $955.0K |
YoY Change | 14.6% | 115.29% | 13.69% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$62.39M | -$60.33M | |
YoY Change | 9.57% | ||
Common Stock | $2.000K | $28.00K | |
YoY Change | -92.86% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $3.233M | $3.154M | $8.711M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $5.879M | $5.210M | $9.666M |
YoY Change | -31.81% | -46.1% | 135.76% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.448M | -$955.0K | -$6.675M |
YoY Change | 120.21% | -85.69% | 625.54% |
Depreciation, Depletion And Amortization | $0.00 | $1.000K | $0.00 |
YoY Change | -100.0% | ||
Cash From Operating Activities | -$1.331M | -$1.964M | -$634.0K |
YoY Change | 54.23% | 209.78% | -8.12% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$1.000K | -$2.000K | -$1.000K |
YoY Change | 100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $1.000K | -$2.000K | -$1.000K |
YoY Change | 100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 2.092M | 0.000 | 3.562M |
YoY Change | -100.0% | -11.61% | |
NET CHANGE | |||
Cash From Operating Activities | -1.331M | -1.964M | -634.0K |
Cash From Investing Activities | 1.000K | -2.000K | -1.000K |
Cash From Financing Activities | 2.092M | 0.000 | 3.562M |
Net Change In Cash | 762.0K | -1.966M | 2.927M |
YoY Change | -188.3% | -167.17% | -12.37% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.331M | -$1.964M | -$634.0K |
Capital Expenditures | -$1.000K | -$2.000K | -$1.000K |
Free Cash Flow | -$1.330M | -$1.962M | -$633.0K |
YoY Change | 54.11% | 209.95% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001326706 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2022Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
usd | |
CY2022Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
usd | |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
usd | ||
CY2022Q3 | NAOV |
Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
|
usd | |
CY2021Q3 | NAOV |
Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
|
usd | |
NAOV |
Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
|
usd | ||
us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
usd | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | ||
NAOV |
Shares Issued From Exercise Of Warrants Previously Classified As Derivative Liability
SharesIssuedFromExerciseOfWarrantsPreviouslyClassifiedAsDerivativeLiability
|
usd | ||
us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
usd | ||
NAOV |
Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
|
usd | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | ||
CY2022Q3 | NAOV |
Warrant Modification Expense
WarrantModificationExpense
|
usd | |
CY2021Q3 | NAOV |
Warrant Modification Expense
WarrantModificationExpense
|
usd | |
NAOV |
Warrant Modification Expense
WarrantModificationExpense
|
usd | ||
CY2021Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
usd | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | ||
NAOV |
Warrant Modification Expense
WarrantModificationExpense
|
usd | ||
NAOV |
Reclass Liability To Equity After Increase In Authorized Shares
ReclassLiabilityToEquityAfterIncreaseInAuthorizedShares
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-36445 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
NanoVibronix, Inc | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
01-0801232 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
525 Executive Blvd. | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Elmsford | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10523 | ||
dei |
City Area Code
CityAreaCode
|
(914) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
233-3004 | ||
dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.001 per share | ||
dei |
Trading Symbol
TradingSymbol
|
NAOV | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
27997793 | shares |
CY2022Q3 | us-gaap |
Cash
Cash
|
1972000 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
7737000 | usd |
CY2022Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
226000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
200000 | usd |
CY2022Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1238000 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
230000 | usd |
CY2022Q3 | us-gaap |
Inventory Net
InventoryNet
|
1553000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
175000 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
4989000 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
8342000 | usd |
CY2022Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
8000 | usd |
CY2022Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
221000 | usd |
CY2021Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
280000 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
5210000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5000 | usd |
CY2022Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
7000 | usd |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
19000 | usd |
CY2022Q3 | NAOV |
Severance Assets Noncurent
SeveranceAssetsNoncurent
|
178000 | usd |
CY2021Q4 | NAOV |
Severance Assets Noncurent
SeveranceAssetsNoncurent
|
207000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
28000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
49000 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
8622000 | usd |
CY2022Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
41000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
87000 | usd |
CY2022Q3 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
1646000 | usd |
CY2021Q4 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
1723000 | usd |
CY2021Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
44000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
28000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
49000 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1715000 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1903000 | usd |
CY2022Q3 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
222000 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
253000 | usd |
CY2022Q3 | us-gaap |
Deferred Income Noncurrent
DeferredIncomeNoncurrent
|
119000 | usd |
CY2021Q4 | us-gaap |
Deferred Income Noncurrent
DeferredIncomeNoncurrent
|
153000 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
2056000 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
2309000 | usd |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27997793 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27997793 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27997793 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27997793 | shares |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
28000 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
28000 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
63449000 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
63162000 | usd |
CY2022Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
3000 | usd |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
60000 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-60326000 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-56937000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3154000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6313000 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5210000 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8622000 | usd |
CY2022Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
97000 | usd |
CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
499000 | usd |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
854000 | usd | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
920000 | usd | |
CY2022Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
17000 | usd |
CY2021Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
271000 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
387000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
407000 | usd | |
CY2022Q3 | us-gaap |
Gross Profit
GrossProfit
|
80000 | usd |
CY2021Q3 | us-gaap |
Gross Profit
GrossProfit
|
228000 | usd |
us-gaap |
Gross Profit
GrossProfit
|
467000 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
513000 | usd | |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
49000 | usd |
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
50000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
176000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
178000 | usd | |
CY2022Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
217000 | usd |
CY2021Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
245000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
760000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
852000 | usd | |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
738000 | usd |
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
801000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2835000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2656000 | usd | |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1004000 | usd |
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
1096000 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
3771000 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
3686000 | usd | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-924000 | usd |
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-868000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3304000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3173000 | usd | |
CY2022Q3 | NAOV |
Financial Expenses Net
FinancialExpensesNet
|
-16000 | usd |
CY2021Q3 | NAOV |
Financial Expenses Net
FinancialExpensesNet
|
-23000 | usd |
NAOV |
Financial Expenses Net
FinancialExpensesNet
|
-47000 | usd | |
NAOV |
Financial Expenses Net
FinancialExpensesNet
|
-29000 | usd | |
CY2021Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-5714000 | usd |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-6956000 | usd | |
NAOV |
Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
|
64000 | usd | |
NAOV |
Warrant Modification Expense
WarrantModificationExpense
|
1627000 | usd | |
CY2022Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-940000 | usd |
CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6605000 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3351000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11721000 | usd | |
CY2022Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
15000 | usd |
CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
70000 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
38000 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
87000 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-955000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6675000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3389000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-11808000 | usd | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.26 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.12 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.47 | ||
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
27997793 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26096957 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
27997793 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
25014919 | shares | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-955000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6675000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3389000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-11808000 | usd | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
6000 | usd |
CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
-1000 | usd |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
57000 | usd | |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
7000 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-999000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6674000 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-3446000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-11815000 | usd | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4164000 | usd |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
35000 | usd |
CY2021Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3000 | usd |
CY2021Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
3558000 | usd |
CY2021Q3 | NAOV |
Adjustments To Additional Paid In Capital Reclass From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassFromLiabilityToEquity
|
7626000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6675000 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8711000 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2394000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
114000 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3000 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7052000 | usd | |
NAOV |
Adjustments To Additional Paid In Capital Reclass From Liability To Equity
AdjustmentsToAdditionalPaidInCapitalReclassFromLiabilityToEquity
|
10963000 | usd | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-7000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-11808000 | usd | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8711000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4134000 | usd |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
116000 | usd |
CY2022Q3 | NAOV |
Adjustments To Additional Paid In Capital Reversal Of Warrants
AdjustmentsToAdditionalPaidInCapitalReversalOfWarrants
|
135000 | usd |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-6000 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-955000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3154000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6313000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
287000 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
135000 | usd | |
NAOV |
Adjustments To Additional Paid In Capital Reversal Of Warrants
AdjustmentsToAdditionalPaidInCapitalReversalOfWarrants
|
135000 | usd | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-57000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3389000 | usd | |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3154000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3389000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-11808000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
287000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
114000 | usd | |
NAOV |
Warrant Modification Expense
WarrantModificationExpense
|
1627000 | usd | |
us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
-12000 | usd | |
us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
-9000 | usd | |
us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-7148000 | usd | |
NAOV |
Gain Loss On Purchase Of Warrants
GainLossOnPurchaseOfWarrants
|
64000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
26000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
4000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1008000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
330000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1378000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
56000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-46000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-82000 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-77000 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-294000 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-78000 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
237000 | usd | |
NAOV |
Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
|
-2000 | usd | |
NAOV |
Increase Decrease In Accrued Severance Pay Net
IncreaseDecreaseInAccruedSeverancePayNet
|
-2000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5704000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3504000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3000 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
4968000 | usd | |
us-gaap |
Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
|
388000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4580000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-57000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-7000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-5765000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1066000 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7737000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7533000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1972000 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8599000 | usd |
NAOV |
Shares Issued From Exercise Of Warrants Previously Classified As Derivative Liability
SharesIssuedFromExerciseOfWarrantsPreviouslyClassifiedAsDerivativeLiability
|
2087000 | usd | |
NAOV |
Reclass Liability To Equity After Increase In Authorized Shares
ReclassLiabilityToEquityAfterIncreaseInAuthorizedShares
|
10963000 | usd | |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_80C_eus-gaap--NatureOfOperations_zJm9aqIqt8Ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_821_zYvhGAh3sNd1">DESCRIPTION OF BUSINESS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NanoVibronix, Inc. (the “Company”), a Delaware corporation, commenced operations on October 20, 2003 and is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s principal research and development activities are conducted in Israel through its wholly owned subsidiary, NanoVibronix (Israel 2003) Ltd., a company registered in Israel, which commenced operations in October 2003.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5704000 | usd | |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1972000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zViTnwcsj6nl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company believe that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
|
57000 | usd | |
us-gaap |
Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
|
7000 | usd | |
CY2022Q3 | us-gaap |
Share Price
SharePrice
|
0.45 | |
CY2021Q3 | us-gaap |
Share Price
SharePrice
|
1.04 | |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
0.45 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
1.04 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0358 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0049 | pure | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.253 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.815 | pure | |
CY2022Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
116000 | usd |
CY2021Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
99000 | usd |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
287000 | usd | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
306000 | usd | |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
250000 | shares |
CY2022Q2 | us-gaap |
Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
|
2029-06-14 | |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.00 | |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
135000000 | usd |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
250000 | shares |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
135000000 | usd |
CY2022Q3 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P7Y | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5286846 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4224199 | shares | |
CY2022Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
97000 | usd |
CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
499000 | usd |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
854000 | usd | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
920000 | usd | |
CY2020Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.19 | |
CY2022Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2000 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
12000 | usd | |
CY2022Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
7 | usd |
CY2021Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
7000 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
9000 | usd | |
CY2022Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
7000 | usd |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
19000 | usd |